Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
grade D 71.43 -0.53% -0.38
NVCR closed down 4.56 percent on Tuesday, October 22, 2019, on 54 percent of normal volume.

Earnings due: Nov 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical NVCR trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -0.53%
Bollinger Band Squeeze Range Contraction -0.53%
20 DMA Resistance Bearish -5.06%
Bollinger Band Squeeze Range Contraction -5.06%
Narrow Range Bar Range Contraction -5.06%
NR7 Range Contraction -5.06%
Inside Day Range Contraction -5.06%
Fell Below 20 DMA Bearish -4.67%
180 Bearish Setup Bearish Swing Setup -4.67%
Bollinger Band Squeeze Range Contraction -4.67%

Older signals for NVCR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Medicine Cancer Clinical Medicine Oncology Non Small Cell Lung Cancer Tumor Ovarian Cancer Glioblastoma Pancreatic Cancer Aging Associated Diseases Brain Tumor European Union Solid Tumor Cancers Mesothelioma
Is NVCR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 98.7
52 Week Low 26.02
Average Volume 755,074
200-Day Moving Average 61.5716
50-Day Moving Average 81.857
20-Day Moving Average 75.1495
10-Day Moving Average 75.61
Average True Range 3.029
ADX 20.27
+DI 17.8647
-DI 30.0706
Chandelier Exit (Long, 3 ATRs ) 73.04290000000001
Chandelier Exit (Short, 3 ATRs ) 80.363
Upper Bollinger Band 78.953
Lower Bollinger Band 71.346
Percent B (%b) 0.06
BandWidth 10.122489
MACD Line -1.3908
MACD Signal Line -1.5181
MACD Histogram 0.1273
Fundamentals Value
Market Cap 6.39 Billion
Num Shares 88.9 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -65.88
Price-to-Sales 13.08
Price-to-Book 13.88
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 78.67
Resistance 3 (R3) 79.39 77.83 77.52
Resistance 2 (R2) 77.83 76.08 77.47 77.14
Resistance 1 (R1) 74.82 75.01 74.04 74.10 76.76
Pivot Point 73.26 73.26 72.87 72.90 73.26
Support 1 (S1) 70.25 71.51 69.47 69.53 66.86
Support 2 (S2) 68.69 70.44 68.33 66.48
Support 3 (S3) 65.68 68.69 66.10
Support 4 (S4) 64.96